emetine has been researched along with rolipram in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Frey, JU; Navakkode, S; Sajikumar, S | 1 |
2 other study(ies) available for emetine and rolipram
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
The type IV-specific phosphodiesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anisomycin; Benzazepines; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Dopamine Antagonists; Emetine; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Nerve Tissue Proteins; Phosphodiesterase Inhibitors; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D5; Receptors, N-Methyl-D-Aspartate; Rolipram; Tetany | 2004 |